About Shah Capital
Shah Capital is a private equity firm founded in 2005. It is primarily based in Raleigh, United States.
Overall Shah Capital portfolio has seen 9 IPOs and 4 acquisitions, namely VEON, Antero Resources and Vitamin Shoppe. A lot of funds co-invest with Shah Capital, with names like NicheTech Computer Solutions sharing a substantial percentage of its portfolio.
Shah Capital has a team of 2 people, including 2 partners.
Key Metrics
Shah Capital's Portfolio
They have invested in a total of 16 companies. Their most recent investment was in MatruBharti (Seed round) on Mar 25, 2023. Here is the most recent investment by Shah Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Mar 25, 2023 | Seed | 9160 | ||
Nov 03, 2014 | Seed | 6589 | ||
Jan 28, 2014 | Series A | 5505 | ||
May 24, 2013 | Series A | 2662 |
Here is the portfolio snapshot of Shah Capital:
Investments by Year
The maximum number of investments were made in 2023
Team profile of Shah Capital
Shah Capital has a team of 2 members including 2 Partners located in India and United States. Shah Capital's team does not sit on the board of any company as of now.Co-investors of Shah Capital
Over the past 21 years, 55 investors have co-invested in Shah Capital's portfolio companies.
- Top Co-investors of Shah Capital: 55 investors entered a company along with Shah Capital. These include investors like NicheTech Computer Solutions (1 company).
Shah Capital News
•
•
•
Canadian Solar Inc. $CSIQ Shares Acquired by Shah Capital ManagementMarketBeat•Aug 22, 2025•Canadian Solar, Shah Capital, Aberdeen
•
Shah Capital Management Invests $6.59 Million in Wolfspeed $WOLFMarketBeat•Aug 22, 2025•Wolfspeed, Shah Capital
•
Shah Capital Management Invests $2.02 Million in Xerox Holdings Co. $XRXMarketBeat•Aug 22, 2025•Shah Capital, Xerox
•
Shah capital management chairman acquires $104,290 in Emeren Group sharesInvesting•Dec 16, 2024•Shah Capital, Emeren
•
•
SK Bioscience sells stake in US vaccine developer NovavaxKedglobal•Aug 16, 2024•SK bioscience, Novavax, Vanguard, BlackRock and 3 others
•
Shah Ends Novavax Proxy Fight Following Sanofi DealLaw360•May 20, 2024•Shah Capital, Novavax, Sanofi
•
_1537179941481.png?format=webp&height=120&width=120)